These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 22591840)

  • 1. Trends in approval of new antimicrobial agents in India compared with the USA.
    Kataria BC; Mehta DS; Mehta SJ
    Int J Antimicrob Agents; 2012 Jul; 40(1):85-6. PubMed ID: 22591840
    [No Abstract]   [Full Text] [Related]  

  • 2. Concerns raised over declining antiinfectives R&D.
    Fox JL
    Nat Biotechnol; 2003 Nov; 21(11):1255-6. PubMed ID: 14595340
    [No Abstract]   [Full Text] [Related]  

  • 3. The drug lag: new drug introductions in India in comparison to United States.
    Karan RS; Malhotra S; Pandhi P
    J Assoc Physicians India; 2002 Jun; 50():782-7. PubMed ID: 12240842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in antimicrobial drug development: implications for the future.
    Spellberg B; Powers JH; Brass EP; Miller LG; Edwards JE
    Clin Infect Dis; 2004 May; 38(9):1279-86. PubMed ID: 15127341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The United States Food and Drug Administration and noninferiority margins in clinical trials of antimicrobial agents.
    Powers JH; Ross DB; Brittain E; Albrecht R; Goldberger MJ
    Clin Infect Dis; 2002 Mar; 34(6):879-81. PubMed ID: 11850875
    [No Abstract]   [Full Text] [Related]  

  • 6. Lost in translation: differences in antimicrobial indication approval policies between the United States and Europe.
    Pappas G; Ierodiakonou V; Falagas ME
    Clin Ther; 2009 Jul; 31(7):1595-603. PubMed ID: 19695409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial agents for complicated skin and skin-structure infections: noninferiority margins, placebo-controlled trials, and the complexity of clinical trials.
    Stevens DL
    Clin Infect Dis; 2009 Aug; 49(3):392-4. PubMed ID: 19555284
    [No Abstract]   [Full Text] [Related]  

  • 8. New antimicrobial agents approved by the U.S. Food and Drug Administration in 2004 and new indications for previously approved agents.
    Antimicrob Agents Chemother; 2005 May; 49(5):2151. PubMed ID: 15855554
    [No Abstract]   [Full Text] [Related]  

  • 9. New antimicrobial agents approved by the U.S. Food and Drug Administration in 2006 and new indications for previously approved agents.
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2649. PubMed ID: 17684007
    [No Abstract]   [Full Text] [Related]  

  • 10. New drugs and product approvals from 1999.
    Gage TW; Taylor SE
    Tex Dent J; 2000 Sep; 117(9):30-47. PubMed ID: 11857846
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost variation of some commonly used antimicrobial agents.
    Dhelia S
    J Indian Med Assoc; 1998 Apr; 96(4):127. PubMed ID: 9844338
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluoroquinolone approved for cattle.
    J Am Vet Med Assoc; 1998 Sep; 213(6):779. PubMed ID: 9743711
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic breakthroughs in the millennium: what to look for in the next two decades. Part 2: New therapeutics reverse old thinking.
    Davidson S
    Health Forum J; 1999; 42(2):61-3. PubMed ID: 10538905
    [No Abstract]   [Full Text] [Related]  

  • 14. A slow start to the new millennium. Zyvox, Concerta and Mifeprex headline the year.
    Cornell S
    Adv Nurse Pract; 2000 Dec; 8(12):62-4. PubMed ID: 12397912
    [No Abstract]   [Full Text] [Related]  

  • 15. HIV drugs. FDA new drug approval rate lowest in 10 years.
    AIDS Policy Law; 2007 Jan; 22(2):5. PubMed ID: 17323437
    [No Abstract]   [Full Text] [Related]  

  • 16. New drug approvals in 2000.
    Wynn RL
    Gen Dent; 2001; 49(4):341-5. PubMed ID: 12016673
    [No Abstract]   [Full Text] [Related]  

  • 17. [Novelties in antimicrobial therapy].
    Vukadinov J; Sević S; Doder R; Grozdana C; Turkulov V
    Med Pregl; 2010; 63 Suppl 1():14-6. PubMed ID: 21438198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamics not likely to appear in antimicrobial labeling soon.
    Thompson CA
    Am J Health Syst Pharm; 2006 Nov; 63(22):2168-72. PubMed ID: 17090729
    [No Abstract]   [Full Text] [Related]  

  • 19. NDA filed for nitazoxanide.
    AIDS Patient Care STDS; 1998 May; 12(5):409-10. PubMed ID: 11361985
    [No Abstract]   [Full Text] [Related]  

  • 20. Trends in development and approval times for new therapeutics in the United States.
    Reichert JM
    Nat Rev Drug Discov; 2003 Sep; 2(9):695-702. PubMed ID: 12951576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.